3 completed, 2 terminated, 1 recruiting. 2 Not applicable, 1 Phase 1, 1 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Recruiting 1 |
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Schizophrenia, Childhood: new trials by email Literature Review of Schizophrenia, Childhood trials Research Report on Schizophrenia, Childhood
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Patientheque in Patients With a Psychosis Blood samples (36 mL) + fecal samples + hair sample - Schizophrenia Prodromal, Schizophrenia, Childhood | Not applicable | Recruiting | University Hospital, Brest | 250 | 2022-07-25 | 2026-06-26 |
| Early Psychosis Intervention - Spreading Evidence-based Treatment NAVIGATE, Treatment as Usual - First Episode Psychosis, Schizophrenia, Childhood | Not applicable | Completed | Centre for Addiction and Mental Health | 100 | 2020-01-03 | 2026-03-18 |
| Daily Intranasal Oxytocin for Childhood-Onset Schizophrenia Intranasal Oxytocin - Childhood Onset Psychotic Disorders, Schizophrenia | Phase 1 / Phase 2 | Terminated | National Institute of Mental Health (NIMH) | 18 | 2012-10-05 | 2017-07-07 |
| Screening for Childhood-Onset Psychotic Disorders Childhood Onset Psychotic Disorders, Schizophrenia | Terminated | National Institute of Mental Health (NIMH) | 123 | 2002-10-29 | 2017-10-09 | |
| Treatment of Childhood Onset Psychiatric Disorders With Intravenous Immunoglobulin (IVIg) Intravenous immunoglobulin - Autoimmune Diseases, Mental Disorders Diagnosed in Childhood | Phase 3 | Completed | National Institute of Mental Health (NIMH) | 10 | 1997-10-01 | 2008-03-04 |
| Comparison of Clozapine vs Olanzapine in Childhood-Onset Psychotic Disorders Olanzapine, Clozapine - Childhood Schizophrenia, Psychotic Disorder | Phase 4 | Completed | National Institute of Mental Health (NIMH) | 25 | 1997-06-01 | 2011-04-12 |
Schizophrenia (6) · Psychotic Disorders (3) · Affective Disorders, Psychotic (1) · Autoimmune Diseases (1) · Neurodevelopmental Disorders (1) · Psychological Well-Being (1) · Schizophrenia Spectrum and Other Psychotic Disorders (1) · Schizotypal Personality Disorder (1)
Mental Disorders (6) · Neurodevelopmental Disorders (5) · Schizophrenia Spectrum and Other Psychotic Disorders (5) · Behavior (1) · Immune System Diseases (1) · Personal Satisfaction (1) · Personality Disorders (1)
Blood Specimen Collection (1) · Clozapine (1) · Immunoglobulins, Intravenous (1) · Olanzapine (1) · Therapeutics (1)
National Institute of Mental Health (NIMH) (4) · Centre for Addiction and Mental Health (1) · University Hospital, Brest (1)
United States (4) · Canada (1) · France (1)
Judith L Rapoport, M.D. (3) · Aristotle Voineskos, MD, PhD (1) · George Foussias, MD, PhD (1) · Janet Durbin, PhD, MSc (1) · Paul Kurdyak, MD, PhD (1) · Sanjeev Sockalingam, MD (1)
PMID 26493637, PMID 16818861, PMID 25936396, PMID 26784704, PMID 29146021, PMID 32499262, PMID 32980206